Results Management

The PASO MC outlined in its Rules how the Results Management Process would be

conducted. In addition, the PASO MC invited Mr. Richard Young, a lawyer with several

years experience in anti-doping, to advice on all potential cases.

During the presence of the IO Team at the Games, no Results Management Hearings

were scheduled. In the last days of the mission the IO Team was informed about three

Adverse Analytical Findings (AAFs) for 16a-hydrodyprednisolone (metabolite of

budesonide). The PASO MC informed the IO Team that they would contact relevant

delegations to understand if the results could be related to the use of any medication

containing budesonide

. Additional AAFs have been reported by the laboratory and the IO

Team attempted to continue to monitor the process in place for these hearings without

success.

After leaving the Games, the IO Team continued to monitor the reporting of AAFs

through ADAMS and observed a lack of follow-up in the results management process.

For example, without knowing if athletes were appropriately notified or not, some AAFs

on the A sample were not followed-up by an immediate notification to the athlete or

request to open the B sample. At least two IFs contacted WADA with a request for

information about their athletes that had an AAF on A samples. For instance, the little

information on these cases was obtained by reading in the media where the IO Team

noticed that athletes had lost medals. After requests to the PASO MC Chair by email on

pending cases, the IO Team finally received partial information on 9 December 2011 on

how these cases have been solved and addressed its concerns on a few cases.

http://www.vogaz.com